Form 4: Ironwood Pharmaceuticals Executive Sells Shares to Cover Tax Obligations

Tammi L. Gaskins, Chief Commercial Officer of Ironwood Pharmaceuticals, sold 2,563 shares of Class A Common Stock to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On May 16, 2025, Tammi L. Gaskins, Chief Commercial Officer of Ironwood Pharmaceuticals, sold 2,563 shares of Class A Common Stock at a price of $0.58 per share.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following the transaction, Gaskins directly owns 242,596 shares of Ironwood Pharmaceuticals' Class A Common Stock.

Sentiment

Score: 6

Explanation: The document describes a routine transaction (sale of shares to cover taxes). It's neutral in sentiment as it doesn't reflect positively or negatively on the company's performance or future outlook.

Management Comments

• The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person.

Industry Context

Executive stock sales to cover tax obligations are a common occurrence, particularly after the vesting of restricted stock units. This type of transaction is generally viewed as routine and not necessarily indicative of the executive's sentiment towards the company's future prospects.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.

Key Dates

Keywords

Form 4, Ironwood Pharmaceuticals, IRWD, Tammi L. Gaskins, Chief Commercial Officer, Stock Sale, Tax Withholding, Restricted Stock Units, Beneficial Ownership